CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-06 | COZADD BRUCE C Chairman & CEO | Sale | −542 | $155.22 | $84K | 356,308 |
| 2022-09-06 | COZADD BRUCE C Chairman & CEO | Option exercise · Non-Qualified Stock Option (right to buy) | −9,700 | 62,905 | ||
| 2022-09-02 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise | +531 | $109.45 | $58K | 11,840 |
| 2022-09-02 | Pearce Samantha SVP, Head of Europe & Internat | Sale | −531 | $156.98 | $83K | 11,309 |
| 2022-09-02 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise · Non-Qualified Stock Option (right to buy) | −531 | 9,563 | ||
| 2022-08-18 | Gray Peter Director | Option exercise | +8,000 | $55.28 | $442K | 22,234 |
| 2022-08-18 | Gray Peter Director | Sale | −8,000 | $158.00 | $1.3M | 14,234 |
| 2022-08-18 | Gray Peter Director | Option exercise · Non-Qualified Stock Option (right to buy) | −8,000 | 0 | ||
| 2022-08-15 | Carr Patricia SVP, Chief Accounting Officer | Sale | −142 | $156.86 | $22K | 5,934 |
| 2022-08-15 | Carr Patricia SVP, Chief Accounting Officer | Option exercise | +2,000 | $113.10 | $226K | 7,934 |
| 2022-08-15 | Carr Patricia SVP, Chief Accounting Officer | Sale | −2,000 | $160.29 | $321K | 5,934 |
| 2022-08-15 | Carr Patricia SVP, Chief Accounting Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −2,000 | 4,500 | ||
| 2022-08-08 | Winningham Rick E Director | Sale | −1,089 | $152.32 | $166K | 8,610 |
| 2022-08-08 | Sohn Catherine A. Director | Sale | −1,089 | $152.32 | $166K | 13,034 |
| 2022-08-08 | Smith Mark Douglas Director | Sale | −1,089 | $152.32 | $166K | 5,891 |
| 2022-08-08 | RIEDEL NORBERT G Director | Sale | −1,089 | $152.32 | $166K | 11,871 |
| 2022-08-08 | ORiordan Anne Director | Sale | −1,089 | $152.32 | $166K | 10,717 |
| 2022-08-08 | O'Keefe Kenneth W Director | Sale | −1,089 | $152.33 | $166K | 21,079 |
| 2022-08-08 | McSharry Heather Ann Director | Sale | −1,179 | $152.32 | $180K | 12,547 |
| 2022-08-08 | McSharry Heather Ann Director | Option exercise | +8,000 | $55.28 | $442K | 20,547 |
Page 23 of 31 · 614 trades